Authors

The Hidden Impact of Pharmacy Supply Chain Disruption on Patient Care  

Pharmacy supply chain disruptions directly shape the treatment that patients receive, making it vital that pharmacists understand the causes and consequences of delays.

How Pharmacists Can Combat Vaccine Hesitancy and Protect Children from Measles Outbreaks

Trusted pharmacist guidance, motivational interviewing, and evidence-based resources help parents make informed pediatric immunization decisions.

Research Underscores the Critical Role of Pharmacists in Managing Stiff Person Syndrome

Stiff Person Syndrome has unique complexities, necessitating the role of pharmacists in managing its symptoms and treatment options.

Pharmacy Deserts: A Crisis Health Care Providers Can Help Solve with Technology and Teamwork

Strategic AI Budgeting for Pharmacies in 2025

Pharmacies can strategically invest in AI technologies to streamline operations and improve patient care while addressing cost challenges and maximizing return on investment in 2025.

Improve Skin Health Through Student Pharmacist Education

Student pharmacists boost dermatology literacy in underserved communities, improving sunscreen habits, skin cancer warning recognition, and practical skin health self-care.

Evaluating Clinical Safety of BTK Inhibitors: Cardiovascular Events and Drug-Drug Interactions

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

Comprehensive Care and Innovation: The Future of Cardiovascular Pharmacy

Emerging therapies, AI, and patient-centered approaches are reshaping cardiovascular pharmacy.

Bridging the Gap: How Housing Status and Race Shape Cancer Screening Disparities

Pharmacy Times interviewed Kimlin Ashing and Narissa Nonzee about their work examining how housing status, race, and ethnicity drive cancer screening disparities.

Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season

Lessons from the past season could strengthen prevention and drive vaccinations for 2025-2026.

ASCO Kickoff: Cancer Vaccines, Cell Therapies, and AI-Driven Precision Oncology Signal the Next Era of Immunotherapy

This interview discusses emerging immunotherapy trends at the 2026 ASCO Annual Meeting, including cancer vaccines, cell-based therapies, ADCs, and AI-driven immune profiling tools poised to reshape oncology care.

Evaluating Clinical Safety of BTK Inhibitors: Cardiovascular Events and Drug-Drug Interactions

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

Not A Laughing Matter: Emerging Nitrous Oxide Regulatory Oversight

Laughing gas misuse is surging as nitrous oxide drug abuse spreads online

Administration of Tivozanib via Gastrostomy Tube: A Pharmacokinetic Analysis

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

Rethinking Pharmacy Workflow: How Smart Roles and Technology Drive Better Care

A practical look at redesigning tasks and integrating artificial intelligence to improve efficiency and patient outcomes

The SUGAR Handshake Could Be a Sweet Option for Safer Diabetes Care

Researchers unveil a pharmacist-led intervention to enhance hypoglycemia management in older adults with type 2 diabetes, improving patient outcomes.

Vitamin C: Does Liposomal Formulation Make a Difference?

Oral liposomal vitamin C dietary supplementation demonstrates improved pharmacokinetics and pharmacodynamics, but a difference on immunity is inconclusive.

Personalized Prevention: Identifying At-Risk Patients With Image-Based Screening

Anna Sophie Mueller, MD discusses how imaging could advance risk identification in cardiovascular care.

GLP-1 Boosters: Responding to Supplement Marketing Claims and Safety Questions

OTC GLP-1 boosters are marketed for weight loss, but pharmacists should help patients distinguish evidence-based care from supplement claims.

FGFR Inhibitors for Treatment of Primary CNS Tumors

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

Emerging Bispecific T-Cell Engagers in Myeloma: Promises and Hurdles

The multiple myeloma landscape is evolving, with bispecific T-cell engagers offering hope.

Elinzanetant: Advancing Treatment for Vasomotor Symptoms

FDA-approved elinzanetant offers stronger nonhormonal relief for menopausal vasomotor symptoms, with promising trial results and simpler liver monitoring.

Outcomes of Older Patients on Enfortumab Vedotin for Urothelial Carcinoma

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

Strengthening Pharmacy Supply Chains: Strategies to Enhance Safety, Reliability, and Resilience

Why smarter supply chain management protects patients and pharmacy operations

From Burnout to Balance: How Walgreens' Hybrid Model Is Addressing the Pharmacy

Walgreens pilots hybrid pharmacists—4 days in-store, 1 day remote—seeking less burnout and more steady staffing.

Opinion: Pharmacists Are Critical to Ensure Safe, Ethical Integration of AI in Health Care

Pharmacists’ expertise is vital to AI’s safe integration into medication management. A growing array of resources and training supports pharmacists’ engagement with this new technology.

Gold Bagging: Setting the Gold Standard for Patients

Gold bagging integrates health system-owned specialty pharmacies with clinical workflows to enhance safety, efficiency, outcomes, and patient experience.

Circulating Tumor DNA (ctDNA) Testing to Predict Response in Solid Tumors

ctDNA analysis revolutionizes cancer treatment by predicting responses, detecting resistance, and monitoring minimal residual disease in patients.

Recap: Tirzepatide Is Approved to Cut Cardiovascular Risk in Type 2 Diabetes

Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.

Guiding Patients Through Allergy Medication Safety: Pharmacists’ Role Following FDA Warning on Cetirizine and Levocetirizine

The FDA is warning of rare severe itching after stopping long-term use of popular allergy medications cetirizine and levocetirizine, urging patient education.